RT Journal Article
SR Electronic
T1 Evaluation of an intelligent digital platform for population management in cervical cancer screening
JF Cancer Biology & Medicine
JO Cancer Biology & Medicine
FD China Anti-Cancer Association
SP 1068
OP 1082
DO 10.20892/j.issn.2095-3941.2025.0419
VO 22
IS 9
A1 Jia, Xinhua
A1 Gao, Chen
A1 Da, Xi’ao
A1 Shi, Jingyi
A1 Chen, Mingyang
A1 Duan, Rufei
A1 Li, Zhifang
A1 Feng, Ruimei
A1 Yang, Yao
A1 Zhai, Jiahuan
A1 Ding, Hanyue
A1 Ng, Alex
A1 Qiao, Youlin
YR 2025
UL http://www.cancerbiomed.org/content/22/9/1068.abstract
AB Objective: To describe temporal changes associated with deployment of an optical character recognition (OCR)-enabled One-Identity (One-ID) digital platform for rural cervical cancer screening, focusing on over-screening rates, CIN2+ detection, colposcopy follow-up, and CIN2+ management.Methods: A multi-county pre-post observational study was conducted in six rural counties in Shanxi, Yunnan, and Sichuan Provinces (2021–2024), encompassing 153,978 encounters. The digital platform integrates OCR identity capture, deterministic One-ID linkage, and real-time duplicate alerts. Over-screening proportions before and after digital deployment were compared, changes in CIN2+ detection rate were evaluated, and colposcopy follow-up and CIN2+ management were assessed. Differences were tested with χ2 or Fisher’s exact tests.Results: Among 153,978 encounters, the proportion of over-screening decreased from 12.64% in 2023 to 0.17% in 2024 with an absolute reduction of 12.17% (95% CI: 11.94–12.40; P < 0.001). The share of women receiving a first screening within the preceding 3 y increased from 78.3% to 88.2% (P < 0.001). Colposcopy completion improved from 64.1% to 84.9%. The CIN2+ detection rate rose from 0.35% (2021–2023 pooled) to 0.67% in 2024 (P < 0.001) and CIN2+ management completion increased from 56.0% to 76.2% (95% CI: 13.3–27.2; P < 0.001). These improvements were consistent across age groups, counties, and screening strategies.Conclusions: The OCR-enabled One-ID platform substantially reduced over-screening, increased CIN2+ detection rate, and strengthened case follow-up/management, particularly where baseline tracking was weak, supporting scalable digital reinforcement of rural screening programmes.The data underlying this article cannot be shared publicly due to the privacy of individuals that participated in the study.